Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes

doi:10.1016/j.tibtech.2014.10.009

Review

. 2015 Jan;33(1):15-26.

doi: 10.1016/j.tibtech.2014.10.009. Epub 2014 Dec 10.

Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes

Tilmann Weber¹, Pep Charusanti², Ewa Maria Musiol-Kroll¹, Xinglin Jiang¹, Yaojun Tong¹, Hyun Uk Kim³, Sang Yup Lee⁴

Affiliations

¹ The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark.
² The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark; Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
³ The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark; Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, BioInformatics Research Center, and BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea.
⁴ The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark; Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, BioInformatics Research Center, and BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea. Electronic address: leesy@kaist.ac.kr.

PMID: 25497361
DOI: 10.1016/j.tibtech.2014.10.009

Review

Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes

Tilmann Weber et al. Trends Biotechnol. 2015 Jan.

. 2015 Jan;33(1):15-26.

doi: 10.1016/j.tibtech.2014.10.009. Epub 2014 Dec 10.

Authors

Tilmann Weber¹, Pep Charusanti², Ewa Maria Musiol-Kroll¹, Xinglin Jiang¹, Yaojun Tong¹, Hyun Uk Kim³, Sang Yup Lee⁴

Affiliations

¹ The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark.
² The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark; Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
³ The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark; Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, BioInformatics Research Center, and BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea.
⁴ The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kogle Alle 6, Hørsholm, Denmark; Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, BioInformatics Research Center, and BioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea. Electronic address: leesy@kaist.ac.kr.

PMID: 25497361
DOI: 10.1016/j.tibtech.2014.10.009

Abstract

Actinomycetes are excellent sources for novel bioactive compounds, which serve as potential drug candidates for antibiotics development. While industrial efforts to find and develop novel antimicrobials have been severely reduced during the past two decades, the increasing threat of multidrug-resistant pathogens and the development of new technologies to find and produce such compounds have again attracted interest in this field. Based on improvements in whole-genome sequencing, novel methods have been developed to identify the secondary metabolite biosynthetic gene clusters by genome mining, to clone them, and to express them in heterologous hosts in much higher throughput than before. These technologies now enable metabolic engineering approaches to optimize production yields and to directly manipulate the pathways to generate modified products.

Keywords: actinomycetes; antibiotics; metabolic engineering; secondary metabolites.

PubMed Disclaimer

Cited by

Combinatorial metabolic engineering of Streptomyces sp. CB03234-S for the enhanced production of anthraquinone-fused enediyne tiancimycins.
Zhuang Z, Kong W, Wen Z, Tong N, Lin J, Zhang F, Fan Z, Yi L, Huang Y, Duan Y, Yan X, Zhu X. Zhuang Z, et al. Microb Cell Fact. 2024 May 4;23(1):128. doi: 10.1186/s12934-024-02399-w. Microb Cell Fact. 2024. PMID: 38704580 Free PMC article.
Development of a group II intron-based genetic manipulation tool for Streptomyces.
Sang Z, Li X, Yan H, Wang W, Wen Y. Sang Z, et al. Microb Biotechnol. 2024 May;17(5):e14472. doi: 10.1111/1751-7915.14472. Microb Biotechnol. 2024. PMID: 38683679 Free PMC article.
Analysis on Changes and Influencing Factors of the Intestinal Microbiota of Alpine Musk Deer between the Place of Origin and Migration.
Zhang B, Shi M, Xu S, Zhang H, Li Y, Hu D. Zhang B, et al. Animals (Basel). 2023 Dec 8;13(24):3791. doi: 10.3390/ani13243791. Animals (Basel). 2023. PMID: 38136828 Free PMC article.
Marine-Derived Streptomyces sennicomposti GMY01 with Anti-Plasmodial and Anticancer Activities: Genome Analysis, In Vitro Bioassay, Metabolite Profiling, and Molecular Docking.
Widada J, Damayanti E, Mustofa M, Dinoto A, Febriansah R, Hertiani T. Widada J, et al. Microorganisms. 2023 Jul 28;11(8):1930. doi: 10.3390/microorganisms11081930. Microorganisms. 2023. PMID: 37630491 Free PMC article.
Rare actinobacteria isolated from the hypersaline Ojo de Liebre Lagoon as a source of novel bioactive compounds with biotechnological potential.
Zamora-Quintero AY, Torres-Beltrán M, Guillén Matus DG, Oroz-Parra I, Millán-Aguiñaga N. Zamora-Quintero AY, et al. Microbiology (Reading). 2022 Feb;168(2):001144. doi: 10.1099/mic.0.001144. Microbiology (Reading). 2022. PMID: 35213299 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- H1 Connect
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes

Affiliations

Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous